Viewing Study NCT00919061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2026-01-31 @ 1:59 PM
Study NCT ID: NCT00919061
Status: COMPLETED
Last Update Posted: 2016-02-03
First Post: 2009-06-11
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Bile Duct Cancer View
None Gallbladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GALL BLADDER View
None BILE DUCTS View
None BAY 43-9006 View
None SORAFENIB View
None CISPLATIN View
None GEMCITABINE View
None 09-029 View